Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningioma | 2 | 2023 | 1221 | 0.860 |
Why?
|
Meningeal Neoplasms | 2 | 2023 | 1255 | 0.840 |
Why?
|
Glioblastoma | 8 | 2023 | 3458 | 0.830 |
Why?
|
Lewy Body Disease | 1 | 2023 | 252 | 0.720 |
Why?
|
Brain Neoplasms | 17 | 2024 | 9101 | 0.680 |
Why?
|
MicroRNAs | 8 | 2023 | 3789 | 0.620 |
Why?
|
Oligonucleotides | 2 | 2019 | 561 | 0.610 |
Why?
|
Astrocytes | 9 | 2017 | 1351 | 0.520 |
Why?
|
Cell Culture Techniques | 2 | 2021 | 1646 | 0.470 |
Why?
|
Tumor Cells, Cultured | 3 | 2021 | 6105 | 0.460 |
Why?
|
Intracranial Hemorrhages | 6 | 2023 | 810 | 0.430 |
Why?
|
Erythrocyte Transfusion | 2 | 2013 | 574 | 0.430 |
Why?
|
Glioma | 6 | 2024 | 3498 | 0.410 |
Why?
|
Blood Group Incompatibility | 1 | 2013 | 134 | 0.400 |
Why?
|
Tuberous Sclerosis | 7 | 2005 | 1039 | 0.400 |
Why?
|
Plasma Exchange | 1 | 2013 | 160 | 0.400 |
Why?
|
Hemolysis | 1 | 2013 | 417 | 0.370 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2823 | 0.330 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2009 | 64 | 0.310 |
Why?
|
Neurofibromatoses | 1 | 2012 | 303 | 0.290 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2004 | 102 | 0.280 |
Why?
|
Cell Division | 6 | 2004 | 4473 | 0.280 |
Why?
|
Relapsing Fever | 1 | 2007 | 25 | 0.280 |
Why?
|
Borrelia | 1 | 2007 | 66 | 0.270 |
Why?
|
Monomeric GTP-Binding Proteins | 2 | 2004 | 199 | 0.260 |
Why?
|
Proteins | 6 | 2004 | 6002 | 0.250 |
Why?
|
Delavirdine | 1 | 2004 | 7 | 0.240 |
Why?
|
Anemia, Sickle Cell | 1 | 2013 | 1063 | 0.230 |
Why?
|
Tumor Suppressor Proteins | 11 | 2005 | 2801 | 0.230 |
Why?
|
Cerebral Infarction | 1 | 2009 | 968 | 0.220 |
Why?
|
Factor VII | 1 | 2004 | 139 | 0.220 |
Why?
|
HIV Reverse Transcriptase | 1 | 2004 | 214 | 0.220 |
Why?
|
Enoxaparin | 2 | 2017 | 391 | 0.220 |
Why?
|
Venous Thromboembolism | 4 | 2018 | 1883 | 0.220 |
Why?
|
Lewy Bodies | 1 | 2023 | 140 | 0.210 |
Why?
|
Anticoagulants | 5 | 2022 | 4854 | 0.200 |
Why?
|
Astrocytoma | 2 | 2023 | 773 | 0.200 |
Why?
|
Oligodendroglioma | 1 | 2023 | 274 | 0.200 |
Why?
|
Cystatins | 1 | 2001 | 55 | 0.190 |
Why?
|
RNA, Small Nuclear | 1 | 2022 | 71 | 0.190 |
Why?
|
Neuropeptides | 2 | 2004 | 950 | 0.190 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2004 | 618 | 0.190 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2001 | 122 | 0.180 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2001 | 75 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2023 | 8623 | 0.180 |
Why?
|
Receptor, IGF Type 1 | 1 | 2023 | 385 | 0.180 |
Why?
|
Blood Component Removal | 1 | 2001 | 124 | 0.180 |
Why?
|
Postoperative Hemorrhage | 1 | 2004 | 418 | 0.170 |
Why?
|
Echo-Planar Imaging | 1 | 2024 | 649 | 0.170 |
Why?
|
Central Nervous System | 2 | 2004 | 1345 | 0.170 |
Why?
|
Lung Transplantation | 1 | 2009 | 1310 | 0.160 |
Why?
|
Repressor Proteins | 5 | 2003 | 2979 | 0.150 |
Why?
|
Genes, bcl-2 | 1 | 1998 | 119 | 0.150 |
Why?
|
Germinal Center | 1 | 2020 | 379 | 0.150 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6066 | 0.140 |
Why?
|
Hippocampus | 3 | 2015 | 3776 | 0.140 |
Why?
|
RNA Splicing | 1 | 2022 | 903 | 0.140 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2018 | 344 | 0.140 |
Why?
|
Oncogenes | 1 | 2022 | 1232 | 0.130 |
Why?
|
Pulmonary Embolism | 1 | 2009 | 2596 | 0.120 |
Why?
|
Caspases | 1 | 1998 | 881 | 0.120 |
Why?
|
Cell Survival | 2 | 2023 | 5749 | 0.120 |
Why?
|
Muscular Diseases | 1 | 2019 | 551 | 0.120 |
Why?
|
Cell Cycle Proteins | 3 | 2003 | 3440 | 0.120 |
Why?
|
E2F1 Transcription Factor | 1 | 2015 | 182 | 0.120 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 17089 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2024 | 3681 | 0.120 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6507 | 0.120 |
Why?
|
Humans | 46 | 2024 | 766812 | 0.110 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2023 | 2763 | 0.110 |
Why?
|
Fever | 1 | 2001 | 1607 | 0.110 |
Why?
|
Epilepsy | 3 | 2005 | 3317 | 0.110 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2014 | 696 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2023 | 10451 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2020 | 1374 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2003 | 317 | 0.110 |
Why?
|
Leukocytes | 1 | 2001 | 2034 | 0.110 |
Why?
|
rap1 GTP-Binding Proteins | 2 | 2003 | 51 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 462 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2022 | 2875 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2015 | 392 | 0.100 |
Why?
|
Apoptosis | 3 | 2015 | 9514 | 0.100 |
Why?
|
Mutation | 6 | 2023 | 30214 | 0.100 |
Why?
|
Guillain-Barre Syndrome | 1 | 2014 | 128 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 926 | 0.100 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2014 | 668 | 0.100 |
Why?
|
Dexamethasone | 1 | 2019 | 1962 | 0.090 |
Why?
|
Alopecia | 1 | 2015 | 416 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1536 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2001 | 2101 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1433 | 0.090 |
Why?
|
Brain | 6 | 2024 | 27158 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 5389 | 0.090 |
Why?
|
Genes, Tumor Suppressor | 2 | 2005 | 1057 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2019 | 2158 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2841 | 0.080 |
Why?
|
Hyperammonemia | 1 | 2010 | 80 | 0.080 |
Why?
|
Ammonia | 1 | 2010 | 245 | 0.080 |
Why?
|
Hepatic Encephalopathy | 1 | 2010 | 143 | 0.080 |
Why?
|
Anti-HIV Agents | 1 | 2004 | 4561 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2015 | 1195 | 0.070 |
Why?
|
Neurofibromatosis 2 | 1 | 2012 | 387 | 0.070 |
Why?
|
Occupational Therapy | 1 | 2009 | 140 | 0.070 |
Why?
|
Cells, Cultured | 8 | 2005 | 18986 | 0.070 |
Why?
|
Animals | 17 | 2022 | 168939 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1621 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4787 | 0.070 |
Why?
|
Mice, Knockout | 6 | 2005 | 14473 | 0.070 |
Why?
|
Syndrome | 1 | 2013 | 3271 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 561 | 0.070 |
Why?
|
Anastomosis, Surgical | 1 | 2009 | 992 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 4523 | 0.060 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2005 | 144 | 0.060 |
Why?
|
Gliosis | 2 | 2003 | 246 | 0.060 |
Why?
|
Neurons | 3 | 2004 | 9515 | 0.060 |
Why?
|
Contact Inhibition | 1 | 2004 | 46 | 0.060 |
Why?
|
Mice | 13 | 2022 | 81898 | 0.060 |
Why?
|
RNA Interference | 2 | 2022 | 2829 | 0.060 |
Why?
|
Antigens, Neoplasm | 3 | 2022 | 1998 | 0.060 |
Why?
|
Male | 15 | 2024 | 364154 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13489 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1884 | 0.060 |
Why?
|
Radiography | 2 | 2020 | 6968 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4968 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2013 | 1594 | 0.060 |
Why?
|
Factor VIIa | 1 | 2004 | 103 | 0.050 |
Why?
|
Aged | 10 | 2023 | 171344 | 0.050 |
Why?
|
Transfection | 4 | 2004 | 5755 | 0.050 |
Why?
|
DNA Primers | 2 | 1998 | 2826 | 0.050 |
Why?
|
Echocardiography, Transesophageal | 1 | 2009 | 1093 | 0.050 |
Why?
|
Species Specificity | 1 | 2007 | 2413 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 1642 | 0.050 |
Why?
|
Cell Size | 1 | 2004 | 625 | 0.050 |
Why?
|
Base Sequence | 3 | 2017 | 12415 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2018 | 65286 | 0.050 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2001 | 91 | 0.050 |
Why?
|
Spliceosomes | 1 | 2022 | 116 | 0.050 |
Why?
|
Potassium | 1 | 2005 | 1314 | 0.050 |
Why?
|
Glutamic Acid | 2 | 2005 | 1181 | 0.050 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2022 | 187 | 0.050 |
Why?
|
Blood Coagulation Disorders | 1 | 2004 | 350 | 0.040 |
Why?
|
Blotting, Western | 3 | 2003 | 5022 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 1998 | 1405 | 0.040 |
Why?
|
Platelet Activation | 1 | 2004 | 643 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8507 | 0.040 |
Why?
|
Glyceryl Ethers | 1 | 2000 | 4 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3692 | 0.040 |
Why?
|
Oligoribonucleotides | 1 | 2000 | 46 | 0.040 |
Why?
|
Protein Kinases | 2 | 2004 | 1610 | 0.040 |
Why?
|
Electronics | 1 | 2021 | 315 | 0.040 |
Why?
|
Thionucleotides | 1 | 2000 | 107 | 0.040 |
Why?
|
Cystatin C | 1 | 2001 | 272 | 0.040 |
Why?
|
Down-Regulation | 2 | 2004 | 2931 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2002 | 663 | 0.040 |
Why?
|
Angiomyolipoma | 1 | 2001 | 189 | 0.040 |
Why?
|
Neurofibromin 2 | 1 | 2001 | 269 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1285 | 0.040 |
Why?
|
Drug Resistance, Viral | 1 | 2004 | 868 | 0.040 |
Why?
|
Retrospective Studies | 8 | 2023 | 81657 | 0.040 |
Why?
|
Neurofibromin 1 | 1 | 2001 | 190 | 0.040 |
Why?
|
Adult | 11 | 2024 | 223305 | 0.040 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 1998 | 68 | 0.040 |
Why?
|
Mutagenesis | 2 | 2003 | 1228 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2001 | 564 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2004 | 2060 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59548 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2010 | 2809 | 0.040 |
Why?
|
Immunoassay | 1 | 2001 | 744 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1998 | 185 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2004 | 1972 | 0.040 |
Why?
|
Endocytosis | 1 | 2002 | 951 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2000 | 515 | 0.040 |
Why?
|
Neuroglia | 1 | 2003 | 960 | 0.040 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2023 | 951 | 0.040 |
Why?
|
Signal Transduction | 5 | 2015 | 23618 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2022 | 1103 | 0.030 |
Why?
|
Female | 13 | 2024 | 396532 | 0.030 |
Why?
|
Middle Aged | 10 | 2024 | 223267 | 0.030 |
Why?
|
Telomerase | 1 | 2001 | 750 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2004 | 1172 | 0.030 |
Why?
|
Incidence | 3 | 2018 | 21527 | 0.030 |
Why?
|
Adenovirus E1A Proteins | 1 | 1995 | 81 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1998 | 542 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13644 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1417 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6514 | 0.030 |
Why?
|
Water | 1 | 2021 | 1416 | 0.030 |
Why?
|
Heterozygote | 1 | 2002 | 2795 | 0.030 |
Why?
|
Up-Regulation | 1 | 2004 | 4143 | 0.030 |
Why?
|
Young Adult | 4 | 2017 | 59939 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2000 | 3053 | 0.030 |
Why?
|
Reference Values | 1 | 2001 | 4914 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2015 | 381 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2039 | 0.030 |
Why?
|
Miller Fisher Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2014 | 44 | 0.030 |
Why?
|
Adenoviridae | 1 | 1998 | 1093 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2003 | 1705 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5702 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3723 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12985 | 0.030 |
Why?
|
Gangliosides | 1 | 2014 | 132 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2014 | 205 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1885 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2003 | 12795 | 0.030 |
Why?
|
Herpesvirus 3, Human | 1 | 2014 | 159 | 0.030 |
Why?
|
Scalp | 1 | 2015 | 390 | 0.030 |
Why?
|
Genotype | 2 | 2004 | 13036 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2014 | 387 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2001 | 1168 | 0.020 |
Why?
|
Sequence Deletion | 1 | 1996 | 1494 | 0.020 |
Why?
|
Virus Activation | 1 | 2014 | 322 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2003 | 13411 | 0.020 |
Why?
|
Fibroblasts | 1 | 2002 | 4166 | 0.020 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 1998 | 882 | 0.020 |
Why?
|
Herpes Zoster | 1 | 2014 | 252 | 0.020 |
Why?
|
Phenotype | 3 | 2004 | 16722 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8540 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3134 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2024 | 4047 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3702 | 0.020 |
Why?
|
Cerebral Cortex | 2 | 2010 | 5753 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2003 | 17609 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4019 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1996 | 996 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2535 | 0.020 |
Why?
|
Radiometry | 1 | 2015 | 814 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2980 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36570 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2016 | 1163 | 0.020 |
Why?
|
Autoantigens | 1 | 2014 | 890 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2015 | 798 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2846 | 0.020 |
Why?
|
Consciousness Disorders | 1 | 2014 | 445 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3942 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2916 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3401 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54872 | 0.020 |
Why?
|
Cell Line | 2 | 2001 | 15564 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2004 | 8045 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4401 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9528 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2004 | 5690 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2413 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29959 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18329 | 0.020 |
Why?
|
Electroencephalography | 1 | 2002 | 6282 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2004 | 11657 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3605 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1995 | 2448 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9744 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12826 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2012 | 1560 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22350 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2201 | 0.020 |
Why?
|
Software | 1 | 2020 | 4464 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 5990 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2003 | 2746 | 0.020 |
Why?
|
Risk Factors | 3 | 2018 | 74889 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1996 | 2952 | 0.020 |
Why?
|
Models, Biological | 1 | 2022 | 9464 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2005 | 185 | 0.020 |
Why?
|
Autoantibodies | 1 | 2014 | 2115 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2631 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2001 | 4282 | 0.010 |
Why?
|
Indoles | 1 | 2012 | 1834 | 0.010 |
Why?
|
Adolescent | 3 | 2010 | 88902 | 0.010 |
Why?
|
Extracellular Space | 1 | 2005 | 563 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7869 | 0.010 |
Why?
|
Thalamus | 1 | 2010 | 1040 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2003 | 323 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4033 | 0.010 |
Why?
|
Hypertrophy | 1 | 2004 | 562 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1982 | 0.010 |
Why?
|
Cerebellum | 1 | 2010 | 1520 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2012 | 2056 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9346 | 0.010 |
Why?
|
Integrases | 1 | 2004 | 520 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 2003 | 315 | 0.010 |
Why?
|
Antisense Elements (Genetics) | 1 | 2001 | 37 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4443 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2004 | 564 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2004 | 9546 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39312 | 0.010 |
Why?
|
Giant Cells | 1 | 2001 | 187 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7612 | 0.010 |
Why?
|
Simian virus 40 | 1 | 2001 | 291 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2001 | 256 | 0.010 |
Why?
|
Oligoribonucleotides, Antisense | 1 | 2000 | 14 | 0.010 |
Why?
|
Electrophysiology | 1 | 2003 | 1263 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11218 | 0.010 |
Why?
|
Codon, Initiator | 1 | 2000 | 50 | 0.010 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2000 | 69 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2004 | 1524 | 0.010 |
Why?
|
Recovery of Function | 1 | 2010 | 2978 | 0.010 |
Why?
|
Acute Disease | 1 | 2010 | 7240 | 0.010 |
Why?
|
Gene Expression | 2 | 2003 | 7585 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1117 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 1995 | 9613 | 0.010 |
Why?
|
Melanocytes | 1 | 2001 | 509 | 0.010 |
Why?
|
ras Proteins | 1 | 2003 | 1055 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2001 | 11062 | 0.010 |
Why?
|
Phosphorylation | 2 | 2001 | 8310 | 0.010 |
Why?
|
Radiation Tolerance | 1 | 2000 | 476 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2003 | 2677 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3587 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2001 | 930 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22248 | 0.010 |
Why?
|
Genes, ras | 1 | 2000 | 656 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24299 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40149 | 0.010 |
Why?
|
Gene Amplification | 1 | 2001 | 1088 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 857 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2093 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1244 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2003 | 3759 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2003 | 1492 | 0.010 |
Why?
|
Molecular Structure | 1 | 2000 | 1882 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9244 | 0.010 |
Why?
|
Alcohol Oxidoreductases | 1 | 1995 | 164 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2000 | 1228 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2003 | 2456 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41706 | 0.010 |
Why?
|
Actins | 1 | 2001 | 2061 | 0.010 |
Why?
|
Synapses | 1 | 2003 | 1759 | 0.010 |
Why?
|
Mice, Nude | 1 | 2000 | 3618 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11876 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1995 | 1159 | 0.010 |
Why?
|
Homeostasis | 1 | 2003 | 3343 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15912 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4168 | 0.010 |
Why?
|
HeLa Cells | 1 | 1995 | 3073 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2001 | 3317 | 0.010 |
Why?
|
Child | 2 | 2010 | 80670 | 0.000 |
Why?
|
Binding Sites | 1 | 1995 | 6013 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1995 | 4780 | 0.000 |
Why?
|
Protein Binding | 1 | 1995 | 9326 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1995 | 5143 | 0.000 |
Why?
|
Transcription Factors | 1 | 2001 | 12159 | 0.000 |
Why?
|
Infant | 1 | 2001 | 36459 | 0.000 |
Why?
|
Child, Preschool | 1 | 2001 | 42577 | 0.000 |
Why?
|